We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Sues to Protect Sensipar, Cites Preparation Process
Teva Sues to Protect Sensipar, Cites Preparation Process
May 29, 2009
Teva Pharmaceutical Industries is suing Amgen for infringing a patent through the sale of a generic version of Sensipar, a treatment for secondary hyperparathyroidism in dialysis patients with chronic kidney disease.